Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05829226
Title A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors PureTech
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Cedars-Sinai Medical Center RECRUITING Los Angeles California 90048 United States Details
University of California Irvine Medical Center RECRUITING Orange California 92868 United States Details
Baptist Health South Florida-Miami Cancer Institute RECRUITING Miami Florida 02114 United States Details
Norton Healthcare-Norton Cancer Institute RECRUITING Louisville Kentucky 40207 United States Details
Mass. General Hospital-Harvard RECRUITING Boston Massachusetts 02114 United States Details
Karmanos Cancer Institute RECRUITING Detroit Michigan 48201 United States Details
Rutgers Cancer Institute of New Jersey RECRUITING New Brunswick New Jersey 08901 United States Details
Rhode Island Hospital RECRUITING Providence Rhode Island 02903 United States Details
Virginia Commonwealth University Medical Center RECRUITING Richmond Virginia 23219 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field